Changes in daily dose in open-label compared to double-blind: The role of clients’ expectations in injectable opioid agonist treatment

Changes in daily dose in open-label compared to double-blind: The role of clients’ expectations in injectable opioid agonist treatment

Introduction: Though double-blind studies have indicated that hydromorphone and diacetylmorphine produce similar effects when administered through injectable opioid agonist treatment (iOAT) programs, participant preference may influence some aspects of medication dispensation such as dose. Methods:...

Full description

Bibliographic Details
Main Authors: Sarin Blawatt, Lourdes Atziri Gonzalez Arreola, Tianna Magel, Scott MacDonald, Scott Harrison, Martin T. Schechter, Eugenia Oviedo-Joekes
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Addictive Behaviors Reports
Subjects:
Opioid use disorder
Injectable opioid agonist treatment
Person-centered care
Drug preference
Diacetylmorphine
Hydromorphone
Online Access:http://www.sciencedirect.com/science/article/pii/S2352853223000123

Internet

http://www.sciencedirect.com/science/article/pii/S2352853223000123

Similar Items